Worsening anemia predicts end-stage renal disease (ESRD) in patients with type 2 diabetes and nephropathy

被引：0
|
作者：
Mohanram, A
Zhang, ZX
Shahinfar, S
Keane, W
Brenner, BM
Toto, RD
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
[2] Merck & Co Inc, W Point, PA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2004年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [1] Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
    Mohanram, A
    Zhang, Z
    Shahinfar, S
    Keane, WF
    Brenner, BM
    Toto, RD
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1131 - 1138
  • [2] ANEMIA OF END-STAGE RENAL-DISEASE (ESRD)
    ESCHBACH, JW
    ADAMSON, JW
    KIDNEY INTERNATIONAL, 1985, 28 (01) : 1 - 5
  • [3] Hematocrit predicts end stage renal disease (ESRD) and non-ESRD mortality in type 1 diabetes with overt nephropathy
    Conway, BN
    Fried, L
    Costacou, T
    Orchard, TJ
    DIABETES, 2005, 54 : A551 - A551
  • [4] Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
    Zhao, Lijun
    Zou, Yutong
    Zhang, Junlin
    Zhang, Rui
    Ren, Honghong
    Lin, Li
    Guo, Ruikun
    Zhang, Jie
    Liu, Fang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (14): : 2113 - 2124
  • [5] The RENAAL ESRD risk score: A risk score system for predicting end-stage renal disease in patients with type 2 diabetes and nephropathy.
    Keane, WF
    Brenner, BM
    De Zeeuw, D
    Grunfeld, JP
    Lash, J
    McGill, J
    Mitch, WE
    Ramjit, D
    Remuzzi, G
    Shahinfar, S
    Snapinn, SM
    Toto, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 249A - 249A
  • [6] The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study
    Keane, WF
    Brenner, BM
    de Zeeuw, D
    Grunfeld, JP
    McGill, J
    Mitch, WE
    Ribeiro, AB
    Shahinfar, S
    Simpson, RL
    Snapinn, SM
    Toto, R
    KIDNEY INTERNATIONAL, 2003, 63 (04) : 1499 - 1507
  • [7] Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
    Shultis, Wendy A.
    Weil, E. Jennifer
    Looker, Helen C.
    Curtis, Jeffrey M.
    Shlossman, Marc
    Genco, Robert J.
    Knowler, William C.
    Nelson, Robert G.
    DIABETES CARE, 2007, 30 (02) : 306 - 311
  • [8] The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy
    Carides, George W.
    Shahinfar, Shahnaz
    Dasbach, Erik J.
    Keane, William F.
    Gerth, William C.
    Alexander, Charles M.
    Herman, William H.
    Brenner, Barry M.
    PHARMACOECONOMICS, 2006, 24 (06) : 549 - 558
  • [9] ANALGESIC NEPHROPATHY - UNCOMMON CAUSE OF END-STAGE RENAL-DISEASE (ESRD)
    MCANALLY, JF
    WINCHESTER, JF
    PIOU, E
    GELFAND, MC
    KNEPSHIELD, JH
    SCHREINER, GE
    CLINICAL RESEARCH, 1979, 27 (05): : A766 - A766
  • [10] The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
    George W. Carides
    Shahnaz Shahinfar
    Erik J. Dasbach
    William F. Keane
    William C. Gerth
    Charles M. Alexander
    William H. Herman
    Barry M. Brenner
    PharmacoEconomics, 2006, 24 : 549 - 558
12345